hexamethylene bisacetamide has been researched along with cytarabine in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (44.44) | 18.7374 |
| 1990's | 5 (55.56) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hassan, HT; Ragab, MH; Rees, JK; Zyada, LE | 1 |
| Dmitrovsky, E; Markman, M; Marks, PA | 1 |
| Andrews, PW; Dignazio, M; Gönczöl, E; Oosterhuis, JW; Plotkin, SA | 1 |
| Chou, TC; Fanucchi, MP; Kong, XB | 1 |
| Gabrilove, JL | 1 |
| Grove, GW; Zweidler, A | 1 |
| Chen, A; Hellinger, N; Licht, JD; Scher, W; Waxman, S; Wu, Y | 1 |
| Grant, S; Jarvis, WD; Rao, AS; Vrana, JA; Wang, Z | 1 |
| Ferrini, PR; Santini, V | 1 |
3 review(s) available for hexamethylene bisacetamide and cytarabine
| Article | Year |
|---|---|
Clinical use of differentiating agents in cancer therapy.
Topics: Acetamides; Animals; Antineoplastic Agents; Cell Differentiation; Cytarabine; Humans; Neoplasms; Retinoids | 1990 |
Differentiation factors.
Topics: Acetamides; Antineoplastic Agents; Calcitriol; Cell Differentiation; Colony-Stimulating Factors; Cytarabine; Humans; Leukemia; Lymphokines; Retinoids; Tetradecanoylphorbol Acetate | 1986 |
Differentiation therapy of myelodysplastic syndromes: fact or fiction?
Topics: Acetamides; Amifostine; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Arginine; Azacitidine; Butyrates; Cholecalciferol; Cytarabine; Harringtonines; Hematopoietic Cell Growth Factors; Heme; Homoharringtonine; Humans; Interferons; Myelodysplastic Syndromes; Retinoids | 1998 |
6 other study(ies) available for hexamethylene bisacetamide and cytarabine
| Article | Year |
|---|---|
New synergistic combinations of differentiation inducing agents in the treatment of acute myeloid leukaemia.
Topics: Acetamides; Antineoplastic Combined Chemotherapy Protocols; Cell Differentiation; Cytarabine; Drug Synergism; Humans; Leukemia, Myeloid; Tretinoin; Tumor Cells, Cultured | 1991 |
Differentiation of TERA-2 human embryonal carcinoma cells into neurons and HCMV permissive cells. Induction by agents other than retinoic acid.
Topics: Acetamides; Bromodeoxyuridine; Butyrates; Butyric Acid; Cell Differentiation; Cell Line; Cisplatin; Clone Cells; Cyclic AMP; Cytarabine; Dimethyl Sulfoxide; Humans; Idoxuridine; Kinetics; Neurons; Teratoma; Tetradecanoylphorbol Acetate; Tretinoin | 1986 |
Antagonistic interactions of hexamethylene bisacetamide in combination with 1-beta-D-arabinofuranosylcytosine, adriamycin and harringtonine on the growth and differentiation of HL-60 cells in vitro.
Topics: Acetamides; Alkaloids; Cell Differentiation; Cell Division; Cytarabine; Doxorubicin; Drug Interactions; Female; Harringtonines; Humans; Leukemia, Promyelocytic, Acute; Software; Tumor Cells, Cultured | 1988 |
Regulation of nucleosomal core histone variant levels in differentiating murine erythroleukemia cells.
Topics: Acetamides; Animals; Cell Differentiation; Cell Line; Cytarabine; Dimethyl Sulfoxide; DNA Replication; Histones; Kinetics; Leukemia, Erythroblastic, Acute; Mice; Nucleosomes | 1984 |
Retinoic acid is required for and potentiates differentiation of acute promyelocytic leukemia cells by nonretinoid agents.
Topics: Acetamides; Butyrates; Cell Differentiation; Cholecalciferol; Cytarabine; Drug Synergism; Humans; In Vitro Techniques; Leukemia, Promyelocytic, Acute; Tretinoin; Tumor Cells, Cultured | 1994 |
Effects of bryostatin 1 and calcium ionophore (A23187) on apoptosis and differentiation in human myeloid leukemia cells (HL-60) following 1-beta-D-arabinofuranosylcytosine exposure.
Topics: Acetamides; Antineoplastic Agents; Apoptosis; Bryostatins; Calcimycin; Calcium; Cell Differentiation; Cytarabine; DNA Fragmentation; HL-60 Cells; Humans; Lactones; Macrolides; Tetradecanoylphorbol Acetate | 1998 |